10-K | 2020-12-31 | Filed 2021-02-26 |
10-Q | 2020-09-30 | Filed 2020-11-06 |
10-Q | 2020-06-30 | Filed 2020-08-07 |
10-Q | 2020-03-31 | Filed 2020-05-11 |
10-K | 2019-12-31 | Filed 2020-02-26 |
10-Q | 2019-09-30 | Filed 2019-11-01 |
10-Q | 2019-06-30 | Filed 2019-08-02 |
10-Q | 2019-03-31 | Filed 2019-05-03 |
10-K | 2018-12-31 | Filed 2019-02-26 |
10-Q | 2018-09-30 | Filed 2018-11-02 |
10-Q | 2018-06-30 | Filed 2018-08-07 |
10-Q | 2018-03-31 | Filed 2018-05-04 |
10-K | 2017-12-31 | Filed 2018-02-27 |
10-Q | 2017-09-30 | Filed 2017-11-07 |
10-Q | 2017-06-30 | Filed 2017-08-03 |
10-Q | 2017-03-31 | Filed 2017-05-04 |
10-K | 2016-12-31 | Filed 2017-02-28 |
10-Q | 2016-09-30 | Filed 2016-11-04 |
10-Q | 2016-06-30 | Filed 2016-08-09 |
10-Q | 2016-03-31 | Filed 2016-05-10 |
10-K | 2015-12-31 | Filed 2016-03-10 |
10-Q | 2015-09-30 | Filed 2015-11-10 |
10-Q | 2015-06-30 | Filed 2015-08-12 |
10-Q | 2015-03-31 | Filed 2015-06-05 |
8-K | 2020-11-05 | |
8-K | 2020-09-22 | |
8-K | 2020-09-22 | |
8-K | 2020-08-06 | |
8-K | 2020-05-19 | |
8-K | 2020-05-11 | |
8-K | 2020-03-31 | |
8-K | 2020-02-27 | |
8-K | 2020-02-24 | |
8-K | 2020-02-24 | |
8-K | 2019-11-20 | |
8-K | 2019-10-30 | |
8-K | 2019-08-01 | |
8-K | 2019-07-29 | |
8-K | 2019-06-21 | |
8-K | 2019-05-28 | |
8-K | 2019-05-23 | |
8-K | 2019-05-23 | |
8-K | 2019-05-02 | |
8-K | 2019-02-27 | |
8-K | 2019-02-27 | |
8-K | 2019-02-25 | |
8-K | 2019-02-21 | |
8-K | 2019-02-05 | |
8-K | 2019-01-02 | |
8-K | 2018-11-01 | |
8-K | 2018-08-06 | |
8-K | 2018-07-10 | |
8-K | 2018-07-06 | |
8-K | 2018-05-31 | |
8-K | 2018-05-23 | |
8-K | 2018-05-02 | |
8-K | 2018-04-16 | |
8-K | 2018-03-29 | |
8-K | 2018-02-26 | |
8-K | 2018-01-29 |
Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546 | 323 | 0 | 0 | 0 | 0 | -854 | |||
1 800 Flowers Com (FLWS) | 944 | 42% | 13.3 | 6% | 665 | 336 | 1,266 | 534 | 37 | 75 | 1,001 |
10x Genomics (TXG) | 4,805 | 75% | -490.3 | -2% | 573 | 151 | 61 | 46 | -10 | -9 | 4,357 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1 | 20 | 1 | 0 | -15 | -15 | 1 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 34 | 0% | 0.4 | -5% | 164 | 108 | 18 | 0 | -8 | -8 | -3 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 19 | 23 | 27 | 7 | -3 | -1 | 3 | |
1895 Bancorp of Wisconsin (BCOW) | 46,153 | 12,508.1 | -0% | 441 | 383 | 0 | 0 | -0 | 4 | 46,142 | |
1st Constitution Bancorp (FCCY) | 165 | 0% | 4.4 | 1% | 1,343 | 1,204 | 0 | 0 | 14 | 33 | 144 |
1st Franklin Financial (FFC) | 4 | -0.6 | 7% | 905 | 645 | 0 | 0 | 62 | 80 | -46 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200 | 7.9 | 1% | 6,691 | 5,858 | 0 | 0 | 70 | 136 | 1,073 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 2 | 0 | 0 | -2 | -2 | 0 | |
21Vianet Group (VNET) | 6,005 | 0% | 11,151 | 5,788 | 0 | 0 | 0 | 0 | 3,344 | ||
22nd Century (XXII) | 302 | 1% | -14.1 | -36% | 62 | 7 | 26 | 0 | -22 | -21 | 302 |
1Life Healthcare (ONEM) |
Balance Sheet ($MM) | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash | 8 | 6 | 7 | 7 | 8 | 10 | 11 | 13 | 17 | 28 | 18 | 16 | 18 | 24 | 20 | 16 | 19 | 20 | 50 |
Accounts Receivable | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
Inventory | |||||||||||||||||||
PP&E | 834 | 920 | 1,018 | 1,079 | 1,158 | 1,345 | 1,521 | 1,734 | 1,762 | 1,815 | 1,922 | 2,105 | 2,223 | 2,268 | 2,358 | 2,391 | 2,565 | 2,726 | 2,742 |
Assets | 864 | 943 | 1,045 | 1,102 | 1,180 | 1,376 | 1,582 | 1,892 | 1,906 | 1,978 | 2,073 | 2,267 | 2,392 | 2,461 | 2,715 | 2,729 | 2,896 | 3,062 | 3,111 |
Accounts Payable | |||||||||||||||||||
Long-Term Debt | 565 | 632 | 873 | ||||||||||||||||
Liabilities | 637 | 437 | 531 | 586 | 655 | 787 | 760 | 913 | 928 | 1,003 | 1,112 | 995 | 1,107 | 1,190 | 1,281 | 1,327 | 1,493 | 1,563 | 1,654 |
Stockholders' Equity | 0 | 234 | 235 | 237 | 236 | 252 | 443 | 577 | 583 | 576 | 566 | 841 | 829 | 821 | 951 | 917 | 893 | 958 | 916 |
Income Statement ($MM) | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Revenue | 85 | 89 | 91 | 95 | 101 | ||||||||||||||
Cost of Revenue | 27 | 26 | 27 | 29 | |||||||||||||||
Gross Profit | 59 | 64 | 68 | 72 | |||||||||||||||
R&D | |||||||||||||||||||
SG&A | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 11 | 11 | 12 | |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
Net Income | 0 | 3 | 4 | 5 | 5 | 7 | 8 | 8 | 7 | 16 | 11 | 12 | 12 | 13 | 17 | 14 | 13 | 18 | 17 |
Cash Flow ($MM) | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash Operating | 10 | 11 | 17 | 14 | 18 | 22 | 27 | 28 | 28 | 27 | 39 | 29 | 34 | 40 | 49 | 46 | 47 | 57 | |
Cash Investing | -8 | -41 | -89 | -38 | -64 | -67 | -213 | -300 | -25 | -67 | -125 | -192 | -105 | -83 | -273 | -144 | -174 | -46 | |
Cash Financing | -2 | 27 | 73 | 24 | 48 | 46 | 187 | 273 | -2 | 50 | 77 | 161 | 73 | 48 | 219 | 100 | 128 | 20 |